Details of the Drug

General Information of Drug (ID: DMMOTIT)

Drug Name

Lintuzumab Ac-226

Indication

Disease Entry	ICD 11	Status	REF
leukaemia	2A60-2B33	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Monoclonal antibody

Cross-matching ID

References

1	J Clin Oncol 29: 2011 (suppl, abstr 6516).